Hypervirulent Klebsiella pneumoniae Infections: A Systematic Review of Clinical, Microbiological, and Outcome Data

Nermin Sakru1, Ender Cetinkaya1, Feza Irem Aldi1

  • 1Department of Medical Microbiology, Trakya University School of Medicine, Edirne, Türkiye.

Microbiologyopen
|June 24, 2026
PubMed

Insights

Hypervirulent Klebsiella pneumoniae (hvKp) causes severe invasive infections, often involving multiple organs. This review highlights common clinical features like bloodstream infections and liver involvement, frequently seen in patients from endemic regions with diabetes.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging pathogen causing severe invasive infections.
  • hvKp infections are increasingly associated with multi-organ involvement and significant morbidity.

Purpose of the Study:

  • To systematically review and summarize the clinical, microbiological, and outcome characteristics of reported hvKp infections.
  • To identify common patterns and risk factors associated with hvKp infections.

Main Methods:

  • A systematic review adhering to PRISMA guidelines was conducted.
  • Searches were performed in PubMed, Scopus, and Web of Science for articles published between 2000 and 2025.
  • Descriptive analyses were performed on individual-level data from 778 cases.

Main Results:

  • Bloodstream infection and liver involvement were frequent clinical presentations.
  • Multi-organ involvement was commonly reported.
  • Most cases originated from or involved travel to endemic regions; diabetes mellitus was a common comorbidity.

Conclusions:

  • This review provides an overview of hvKp infection characteristics, noting frequent clinical and microbiological patterns.
  • Findings are based on heterogeneous, severe cases and require cautious interpretation.
  • Further research with standardized data collection is necessary for better characterization.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...